Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid

Poole, 1993, Osteoarthritis in the human knee: a dynamic process of cartilage matrix degradation, synthesis and reorganization, Agents Actions Suppl, 39, 3

Buckwalter, 2001, The increasing need for nonoperative treatment of patients with osteoarthritis, Clin Orthop, 385, 36, 10.1097/00003086-200104000-00008

Day, 2004, A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee, J Rheumatol, 31, 775

Shimazu, 1993, Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines, Arthritis Rheum, 36, 247, 10.1002/art.1780360217

Gotoh, 1993, Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats, Ann Rheum Dis, 52, 817, 10.1136/ard.52.11.817

Asari, 1998, Molecular weight-dependent effects of hyaluronate on the arthritic synovium, Arch Histol Cytol, 61, 125, 10.1679/aohc.61.125

Creamer, 1999, Intra-articular corticosteroid treatment in osteoarthritis, Curr Opin Rheumatol, 11, 417, 10.1097/00002281-199909000-00016

Leopold, 2003, Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee: a prospective, randomized trial, J Bone Joint Surg Am, 85, 1197, 10.2106/00004623-200307000-00003

Jones, 1995, Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexaceton- ide in inflammatory knee osteoarthritis, Osteoarthritis Cartilage, 3, 269, 10.1016/S1063-4584(05)80018-4

Caborn, 2004, Murray C; Synvisc 901 Study Group. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexace- tonide in patients with osteoarthritis of the knee, J Rheumatol, 31, 333

Witter, 1987, The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis, Arthritis Rheum, 30, 519, 10.1002/art.1780300506

Lohmander, 1993, The structure of aggrecan fragments in human synovial fluid: evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis, Arthritis Rheum, 36, 1214, 10.1002/art.1780360906

Okada, 1992, Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties, J Biol Chem, 267, 21712, 10.1016/S0021-9258(19)36670-0

Kanyama, 2000, Matrix metalloproteinases and tissue inhibitors of metal- loproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis, J Orofac Pain, 14, 20

Smith, 2003, A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee, Rheumatology, 42, 1477, 10.1093/rheumatology/keg398

Kellgren, 1957, Radiological assessment of osteoarthrosis, Ann Rheum Dis, 16, 494, 10.1136/ard.16.4.494

Gotoh, 2001, Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial, Clin Exp Rheumatol, 19, 377

Reissig, 1955, A modified colorimetric method for the estimation of N-acetylamino sugars, J Biol Chem, 217, 959, 10.1016/S0021-9258(18)65959-9

Shinmei, 1992, Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid, Arthritis Rheum, 35, 1304, 10.1002/art.1780351110

Fujimoto, 1994, A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloprotein- ase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies, Clin Chim Acta, 231, 79, 10.1016/0009-8981(94)90256-9

Kodama, 1987, Monoclonal antibodies to bovine collagenase inhibitor, Coll Relat Res, 7, 341, 10.1016/S0174-173X(87)80027-4

Pelletier, 1989, In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage, J Rheumatol, 16, 646

Hasegawa, 2008, Changes in biochemical markers and prediction of effectiveness of intra-articular hyaluronan in patients with knee osteoarthritis, Osteoarthritis Cartilage, 16, 526, 10.1016/j.joca.2007.09.014

Iwata, 1993, Pharmacologic and clinical aspects of intraarticular injection of hyaluronate, Clin Orthop, 289, 285, 10.1097/00003086-199304000-00042

Tchetverikov, 2004, MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis, Ann Rheum Dis, 63, 881, 10.1136/ard.2003.013243

Fraser, 2001, Matrix metal-loproteinase 9, apoptosis, and vascular morphology in early arthritis, Arthritis Rheum, 44, 2024, 10.1002/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K

Hsieh, 2008, Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis, J Orthop Res, 26, 475, 10.1002/jor.20524